(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 in JAMA Cardiology.
Jan 4, 2017
0
0
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.
Jan 4, 2017
0
16
Despite recommendations, less than 45 percent of adults younger than 40 years with an elevated low-density lipoprotein cholesterol (LDL-C) level of 190 mg/dL or greater receive a prescription for a statin, according to a ...
Jan 4, 2017
0
1
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of "good" cholesterol, despite being treated ...
Dec 28, 2016
0
2
In a study published online by JAMA Cardiology, Sripal Bangalore, M.D., M.H.A., of the New York University School of Medicine, New York, and colleagues examined national trends in perioperative cardiovascular outcomes and ...
Dec 28, 2016
0
0
Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new Northwestern Medicine study.
Dec 21, 2016
0
2
In a study published online by JAMA Cardiology, Euan A. Ashley, M.B., Ch.B., D.Phil., of the Stanford University, Stanford, Calif., and colleagues assessed the feasibility of measuring physical activity, fitness, and sleep ...
Dec 14, 2016
0
1
Widespread ownership of smartphones around the world could potentially transform cardiovascular research by providing rapid, large-scale and real-time measurement of individuals' physical activity, according to a new study ...
Dec 14, 2016
0
6
In a study published online by JAMA Cardiology, Asher Rosinger, Ph.D., M.P.H., of the Centers for Disease Control and Prevention, Hyattsville, Md., and colleagues examined whether earlier trends of a decline (between 1999 ...
Nov 30, 2016
0
0
From 2002 to 2013, the use of statins increased substantially among U.S. adults, although use in high-risk groups remains suboptimal, and there are persistent disparities among women, racial/ethnic minorities, and the uninsured, ...
Nov 14, 2016
0
0
